BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Judson MA. Quality of Life Assessment in Sarcoidosis. Clin Chest Med 2015;36:739-50. [PMID: 26593146 DOI: 10.1016/j.ccm.2015.08.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Mañá J, Rubio-Rivas M, Villalba N, Marcoval J, Iriarte A, Molina-Molina M, Llatjos R, García O, Martínez-Yélamos S, Vicens-Zygmunt V, Gámez C, Pujol R, Corbella X. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Medicine (Baltimore) 2017;96:e7595. [PMID: 28723801 DOI: 10.1097/MD.0000000000007595] [Cited by in Crossref: 42] [Cited by in F6Publishing: 12] [Article Influence: 8.4] [Reference Citation Analysis]
2 Tanizawa K, Handa T, Nagai S, Oga T, Kubo T, Ito Y, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Hirai T, Chin K, Mishima M, Izumi T. Can the Sarcoidosis Health Questionnaire predict the long-term outcomes in Japanese sarcoidosis patients? Respiratory Medicine 2019;149:1-8. [DOI: 10.1016/j.rmed.2019.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Jeny F, Bouvry D, Freynet O, Soussan M, Brauner M, Planes C, Nunes H, Valeyre D. Management of sarcoidosis in clinical practice. Eur Respir Rev 2016;25:141-50. [DOI: 10.1183/16000617.0013-2016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
4 Baughman RP, Judson MA, Wells A. The indications for the treatment of sarcoidosis: Wells Law. Sarcoidosis Vasc Diffuse Lung Dis 2017;34:280-2. [PMID: 32476859 DOI: 10.36141/svdld.v34i4.6957] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Strookappe B, Saketkoo LA, Elfferich M, Holland A, De Vries J, Knevel T, Drent M. Physical activity and training in sarcoidosis: review and experience-based recommendations. Expert Rev Respir Med 2016;10:1057-68. [PMID: 27552344 DOI: 10.1080/17476348.2016.1227244] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
6 Obi ON. Health-Related Quality of Life in Sarcoidosis. Semin Respir Crit Care Med 2020;41:716-32. [PMID: 32583381 DOI: 10.1055/s-0040-1710080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Vis R, van de Garde EMW, Meek B, Korenromp IHE, Grutters JC. Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis. Respir Med 2020;165:105936. [PMID: 32308204 DOI: 10.1016/j.rmed.2020.105936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Judson MA, Preston S, Hu K, Zhang R, Jou S, Modi A, Sukhu I, Ilyas F, Rosoklija G, Yucel R. Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis. Respir Med 2019;152:14-9. [PMID: 31128604 DOI: 10.1016/j.rmed.2019.03.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Chopra A, Kalkanis A, Judson MA. Biomarkers in sarcoidosis. Expert Rev Clin Immunol 2016;12:1191-208. [PMID: 27253883 DOI: 10.1080/1744666X.2016.1196135] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
10 Judson MA. Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns. F1000Res 2019;8:F1000 Faculty Rev-2149. [PMID: 31942239 DOI: 10.12688/f1000research.20696.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
11 Wilsher ML. Friend or foe? Corticosteroids in sarcoidosis. Respirology. [DOI: 10.1111/resp.14219] [Reference Citation Analysis]
12 Judson MA, Yucel R, Preston S, Chen ES, Culver DA, Hamzeh N, Lower EE, Sweiss NJ, Valeyre D, Veltkamp M, Victorson DE, Beaumont JL, Singh N, Shivas T, Vancavage R, Baughman RP. The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: Results from the On-line Sarcoidosis Assessment Platform Study (OSAP). Respiratory Medicine 2022. [DOI: 10.1016/j.rmed.2022.106819] [Reference Citation Analysis]